Fauci at AHIP: We need a better public health strategy for the next pandemic

The latest stories trending on MedCity News.

ddg

Editor's Pick

Top Story Are We Prepared for the Next Pandemic? Anthony Fauci Weighs In at AHIP While the U.S. did very well on the scientific front of Covid-19 with the production of vaccines, it needs to improve on the public health front, said Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases. He made these comments Tuesday at the AHIP 2023 conference in Portland. Partnership Content Canada and the Midwest in Life Sciences, 75 Years in the Making Presented by MedCity News & Global Affairs Canada The Consulate General of Canada in Chicago is currently celebrating the 75th anniversary of its diplomatic presence in the Midwest. Learn More>> Calling All FemTech Startups Startups in this category are software and medical technology companies that are addressing various aspects of female physical and mental health. We are now accepting FemTech Pitch Perfect submissions for MedCity INVEST Digital Health, which is taking place on October 26, 2023 at Pegasus Park in Dallas, TX. Submit your application today.

Featured News

Which Digital Health Tools Will Be the Greatest Victim to Turnover from Hospitals? Hospitals' digital health adoption exploded during the pandemic, leading to many vendor contracts spanning three to five years. As these contracts reach their expiration dates over this year and next, a new report predicts that telemedicine platforms and remote patient monitoring tools face the highest risk of being turned over by hospitals. Cala Health Launches Wearable Device to Treat Hand Tremors Cala Health recently launched its kIQ system — which it calls the first noninvasive wearable device cleared by the FDA to temporarily relieve tremors in people with essential tremor and Parkinson's disease. Patient Death Leads to Pause in Test of 2seventy Bio Cell Therapy for Leukemia 2seventy Bio reported that an acute myeloid leukemia patient treated with its experimental cell therapy has died, prompting research partner Seattle Children's Research Institute to pause the Phase 1 study. The FDA has been notified and an investigation is underway. In the GLP-1 Era, Clinical Guidelines for Obesity Care Are Urgently Needed While the attention GLP-1s are receiving is exciting for medical professionals like me who've specialized in obesity treatment for decades, with little fanfare, the 'miracle drug' message is misleading and harmful.

Resources

Why Effective and Efficient Clinical Trial Operations Are More Complex and More Important than Ever in a Post-Pandemic World Presented by Allucent Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape.

MedCity News • PO Box 901 • New York, NY unsubscribe